In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
EP Lab Digest highlights Tampa General Hospital’s NeuroCardiac Program, a unique, collaborative approach to patient care that is shaping the future of heart-brain health.
EP Lab Digest highlights Tampa General Hospital’s NeuroCardiac Program, a unique, collaborative approach to patient care that is shaping the future of heart-brain health.
The JIC Podcast is the official podcast of the Journal of Invasive Cardiology. The Journal of Invasive Cardiology (JIC) is a peer-reviewed scientific medical journal serving clinicians who treat cardiovascular disease.
The JIC Podcast is the official podcast of the Journal of Invasive Cardiology. The Journal of Invasive Cardiology (JIC) is a peer-reviewed scientific medical journal serving clinicians who treat cardiovascular disease.
Dee Dee Wang, MD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
In this interview, Drs Bhatt and Wang discuss the Door-To-Unload (DTU)-STEMI pilot trial, set up to evaluate the safety and feasibility of LV unloading and delayed reperfusion in patients with STEMI.
In this interview, Drs Bhatt and Wang discuss the Door-To-Unload (DTU)-STEMI pilot trial, set up to evaluate the safety and feasibility of LV unloading and delayed reperfusion in patients with STEMI.
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Emmanouil Brilakis discusses the largest meta-analysis to date investigating the impact of CTO-PCI on clinical events during long-term follow-up. The analysis (Simsek et al), included 58 publications containing a total of 45,527 who underwent...
Emmanouil Brilakis discusses the largest meta-analysis to date investigating the impact of CTO-PCI on clinical events during long-term follow-up. The analysis (Simsek et al), included 58 publications containing a total of 45,527 who underwent...
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis discuss coronary perforation, a rare but potentially life-threatening complication of PCI.
Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis discuss coronary perforation, a rare but potentially life-threatening complication of PCI.
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
SALT LAKE CITY, UT — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
Blood clot removal...
SALT LAKE CITY, UT — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
Blood clot removal...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.1...
Munich, Germany – With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.1...
In this session from CRT 2026, Dr Nassir F. Marrouche of Tulane University presented the latest evidence positioning pulsed field ablation as a transformative advance in AF ablation.
In this session from CRT 2026, Dr Nassir F. Marrouche of Tulane University presented the latest evidence positioning pulsed field ablation as a transformative advance in AF ablation.
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
In this CRT 2026 interview, Dr Andreas Sarantopoulos of the NCH Rooney Heart Institute discusses his Top Abstract on machine learning for predicting recurrent atrial fibrillation and its implications for interventional cardiology practice.
In this CRT 2026 interview, Dr Andreas Sarantopoulos of the NCH Rooney Heart Institute discusses his Top Abstract on machine learning for predicting recurrent atrial fibrillation and its implications for interventional cardiology practice.
In his session at CRT 2026, Dr Eric Secemsky reviewed contemporary data linking sympathetic overactivity to heart failure, atrial fibrillation, and cardiometabolic disease, and examined how renal and multi-organ denervation may modify these...
In his session at CRT 2026, Dr Eric Secemsky reviewed contemporary data linking sympathetic overactivity to heart failure, atrial fibrillation, and cardiometabolic disease, and examined how renal and multi-organ denervation may modify these...
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
In this interview from CRT 2026, Dr Eric A. Secemsky of Beth Israel Deaconess Medical Center speaks about the current status of renal denervation as a management strategy for atrial fibrillation and hypertension.
In this interview from CRT 2026, Dr Eric A. Secemsky of Beth Israel Deaconess Medical Center speaks about the current status of renal denervation as a management strategy for atrial fibrillation and hypertension.
At CRT 2026, Dr Sanjit S. Jolly of McMaster University presented the most recent developments in combination therapy for atrial fibrillation and the highly anticipated LAAOS IV trial.
At CRT 2026, Dr Sanjit S. Jolly of McMaster University presented the most recent developments in combination therapy for atrial fibrillation and the highly anticipated LAAOS IV trial.
Leila Alizadeh, MD; Maria Eleni Drosou, MD; Takayuki Onishi, MD; Roya Anahita Mousavi, MD; Amit Hooda, MD; Sahil Khera, MD, MPH; Lucy M. Safi, DO; George D. Dangas, MD, PhD; Gilbert H.L. Tang, MD, MSc, MBA; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Stamatios Lerakis, MD, PhD
An 80-year-old man presented with dyspnea. Nine years earlier, he had undergone transcatheter aortic valve replacement with a 29-mm Evolut R self-expanding valve (Medtronic) following aborted surgical aortic valve replacement due to extensive...
An 80-year-old man presented with dyspnea. Nine years earlier, he had undergone transcatheter aortic valve replacement with a 29-mm Evolut R self-expanding valve (Medtronic) following aborted surgical aortic valve replacement due to extensive...
